Long-term results with rifampicin together with ethambutol and-or other drugs in the treatment of tuberculosis with cultures resistant to the standard drugs.
D000328:Adult; D000368:Aged; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D004338:Drug Combinations; D004977:Ethambutol; D012293:Rifampin